As part of our continued commitment to compliance, Alere Inc. (“Alere”), has developed and implemented a Compliance Program that is consistent with the HHS OIG Compliance Program Guidance for Pharmaceutical Manufacturers. The Alere Compliance Program includes policies designed to incorporate guidance contained in the AdvaMed Code of Ethics on Interactions with Healthcare Providers. To our knowledge as of the date of this declaration, Alere is in compliance with our Compliance Program, as described here, and with California Health & Safety Code Sections 119400-119402. We will evaluate and update our Compliance Program, as necessary and appropriate.
This declaration covers all of the members of the Alere family of companies.
To obtain a print version of this Declaration or a copy of our Compliance Program, please write to our Corporate Compliance Department: 51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Not all products are available in all regions. Check with your local representative for availability in specific markets. For In Vitro Diagnostic Use Only. For the use of registered medical practitioners, hospitals and Laboratories only.
Based on your current location, the content on this page may not be relevant for your country.
